Dr. Burcu Darst received her PhD in Epidemiology from the University of Wisconsin and recently completed post-doctoral training at the University of Southern California under the mentorship of Drs. Christopher Haiman and David Conti. Dr. Darst's research is focused on identifying and understanding genetic and multi-omic risk factors of prostate cancer in diverse populations. She has extensive expertise in genetic epidemiology as well as genetic association and metabolomic investigations. Her research focuses on understanding genetic risk of prostate cancer in multi-ancestry populations, particularly using rare variants captured with whole exome sequencing, genome-wide association studies, polygenic risk scores and metabolomics to distinguish aggressive from non-aggressive disease and to understand the stark health disparities that contribute to prostate cancer risk. She has also done research on genetic testing in precision medicine, developmental neurogenetics, and the genetics of complex aging traits and worked to integrate genomic and metabolomic data to understand the underlying mechanisms contributing to complex aging traits and Alzheimer’s disease. Currently, she is leading an effort to improve understanding of the genomic and metabolic mechanisms contributing to prostate cancer risk in men from diverse populations as well as improving the utility of polygenic risk scores and rare genetic variants for the prediction of prostate cancer across patient populations. Dr. Darst has received multiple awards for her work including the Prostate Cancer Foundation Young Investigator Award and the AACR NextGen Star award.